Literature DB >> 25316744

Generic versus brand name: the other drug war.

James McCormack1, John T Chmelicek2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25316744      PMCID: PMC4196814     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

1.  Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Authors:  Barbara M Davit; Patrick E Nwakama; Gary J Buehler; Dale P Conner; Sam H Haidar; Devvrat T Patel; Yongsheng Yang; Lawrence X Yu; Janet Woodcock
Journal:  Ann Pharmacother       Date:  2009-09-23       Impact factor: 3.154

2.  Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies.

Authors:  Aaron S Kesselheim; Katsiaryna Bykov; Jerry Avorn; Angela Tong; Michael Doherty; Niteesh K Choudhry
Journal:  Ann Intern Med       Date:  2014-07-15       Impact factor: 25.391

3.  Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

Authors:  B J Dong; W W Hauck; J G Gambertoglio; L Gee; J R White; J L Bubp; F S Greenspan
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

Review 4.  Brand name versus generic warfarin: a systematic review of the literature.

Authors:  Francesco Dentali; Marco P Donadini; Nathan Clark; Mark A Crowther; David Garcia; Elaine Hylek; Dan M Witt; Walter Ageno
Journal:  Pharmacotherapy       Date:  2011-04       Impact factor: 4.705

Review 5.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

  5 in total
  1 in total

1.  Examining patterns in medication documentation of trade and generic names in an academic family practice training centre.

Authors:  Alexander Summers; Carly Ruderman; Fok-Han Leung; Morgan Slater
Journal:  BMC Med Educ       Date:  2017-09-22       Impact factor: 2.463

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.